SR One - Applying insight. Creating value SR One is GlaxoSmithKline's independent corporate healthcare venture capital fund. We invest globally in emerging biotech companies that are focused on drug discovery, development or delivery and have the potential to make products that will have a dramatic benefit to patients. Srone.com~Site InfoWhoisTrace RouteRBL Check